The study is focused on whether doxycycline may slow the progression of emphysema (a type of chronic obstructive pulmonary disease), in people with well-controlled HIV who are current or former smokers.
Dr. Johnson has mentored investigators working on some of the world's most virulent infectious diseases, from HIV/AIDS to malaria, hepatitis, leptospirosis, schistosomiasis, tuberculosis, leishmaniasis, and cryptosporidiosis.
The Tri-institutional TB Research Advancement Center (TRAC) is a collaboration between an exceptional group of investigators at Weill Cornell Medicine, Cornell University, Rockefeller University, and Memorial Sloan Kettering Cancer Center.
This award was initiated by Dr. Ralph Nachman in 2002 to recognize outstanding research during fellowship training.
GHESKIO founder and the Howard and Carol Holtzmann Professor in Clinical Medicine, Dr. Jean Pape has been elected to the American Academy of Arts and Sciences.
The Weill Department of Medicine has announced five winners who will receive Fund for the Future (FFF) awards.
Drs. Koen Van Besien, Jingmei Hsu, and Marshall Glesby have led a clinical trial involving a patient living with HIV who has now been free of the virus for 14 months.
Dr. Blackwell was the first woman in the United States to become an M.D. The occasion was in honor of National Women Physicians Day held on February 3, 2022.
This one-time grant will support Dr. Morales’s project focused on understanding the role of an oncoprotein, Wilms' Tumor 1, in HIV-Associated Kaposi Sarcoma.
Lectures were provided by WDOM faculty and keynote speaker, Dr. Drew Weissman, who played a major role in critical discoveries that allowed for the mRNA platform to be used in developing vaccines against SARS-CoV.